In light of our prior finding of C‐myc down‐regulation in hepatocellular carcinoma, we sought to explore whether the effect of ML treatment in SCLC is at least partially mediated through modulation of myc expression. The gene discussed is MYC; the disease is small cell lung carcinoma.